Navigation Links
Le Dr Elizabeth H. Blackburn, lauréate du Prix Nobel, se joint au panel du DÉBAT SUR L'INNOVATION D'ASTELLAS 2013
Date:11/17/2013

/span>.

Le professeur Tim Eisen          Professeur d'oncologie médicale à l'université de Cambridge.

À propos du Débat sur l'innovation d'Astellas

Le débat sur l'innovation d'Astellas, organisé et financé par Astellas Pharma Europe Ltd., se penche sur le rôle de l'innovation dans la société moderne.

L'événement de cette année, sur le thème « The Age Crunch: Facts fears and the future », aura lieu le 19 novembre 2013 à la Royal Institution de Grande-Bretagne et réunira des personnalités influentes et respectées des domaines des sciences, du gouvernement, de la médecine, de l'économie, de l'industrie et des médias. Les participants s'attaqueront aux problèmes majeurs liés à l'innovation scientifique d'aujourd'hui et de demain. L'objectif du Débat sur l'innovation consiste à aborder des problèmes cruciaux, de tirer des conclusions positives et de faire avancer le programme.

Tout le monde, à savoir les professionnels dans les domaines des sciences, de la médecine et de l'industrie ainsi que le grand public, aura l'occasion de participer au Débat sur l'innovation d'Astellas par le biais des médias en ligne qui porteront la discussion bien au-delà des murs de la Royal Institution de Grande-Bretagne.

La première édition du Débat sur l'innovation qui a eu lieu en novembre 2012 à la Royal Society de Londres a mis l'accent sur l'innovation en période d'austérité et la formation des innovateurs du futur. Sous la présidence du professeur Jim Al-Khalili ce débat a réuni des intervenants comme le professeur Sir Andre Geim, lauréat du <
'/>"/>

SOURCE Astellas Pharma Europe Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
2. Gallus Strengthens Biologics CMO Business with Acquisition of Laureate
3. Nobel Laureate Dr. Oliver Smithies to Deliver Plenary Session at ISPE Biotechnology Symposium
4. Syngentas Mary-Dell Chilton named 2013 World Food Prize laureate
5. Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, a Top Priority Addressed in the 2013 Presidential State of The Union, Files Lawsuit Against 2012 Nobel Laureate Dr. Yamanaka for Deception
6. Dr. Rongxiang Xu, Owner of Patented Technology to Regenerate Damaged Organs, Announces Lawsuit Against 2012 Nobel Laureate Dr. Shinya Yamanaka
7. The Energy Scientific World Acclaims the Global Energy Prize 2012 Laureates
8. Laureate Biopharma Names James D. Utterback to Board of Directors
9. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
10. Novogen Launches Joint Venture Aimed At Developing Drugs to Fight Ovarian Cancer
11. Tampa's Personal Injury Chiropractor at Elan Wellness Center, Announces New Health Care Options for Patients with Back, Joint, Muscle, and Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... PARK, Calif. , March 2, 2015  Asterias ... in the emerging field of regenerative medicine, today announced ... 2014 financial and operating results on Tuesday, March 10, ... The Company will host a conference call and webcast ... / 1:30 p.m. Pacific to discuss the results and ...
(Date:3/2/2015)... Boston, Massachusetts (PRWEB) March 02, 2015 ... legal services, today announced the addition of Debbie Casey ... group’s capabilities in the healthcare space. , ... industry, most of which with Fresenius Medical Care North ... will leverage her extensive experience to work with Outside ...
(Date:2/27/2015)... SUMMERLAND, British Columbia , Feb. 27, ... XON ), a leader in synthetic biology, today announced ... Specialty Fruits (OSF), the pioneering agricultural company behind ... first non-browning apple. Through the acquisition, Intrexon expands its ... more appetizing and convenient for consumers while providing economic ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine ... and immunotherapy company, today announced that the U.S. ... for Fast Track designation and Phase I clinical ... conjunction with the mutual co-development agreement signed with ... Fast Track designation for the DPX-Survivac. , “We ...
Breaking Biology Technology:Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Outside GC Expands Healthcare Team 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
... This release is available in Spanish . ... leading in Spain the European project within the VII Framework ... buildings which host large numbers of people, such as sports ... by the management and optimisation of energy in its three ...
... 5, 2011 Sangamo BioSciences, Inc. (Nasdaq: SGMO ... will provide an update on the progress of Sangamo,s ZFP ... strategy at 12:30 pm PT (3:30 pm ET) on Thursday, ... Conference which will be held in San Francisco. ...
... HOUSTON, Jan. 5, 2011 International energy pricing agency ... expansion into US and Canadian wood chip pricing complements ... broader European biomass indexation. " Argus understands ... to be at the forefront, providing transparency to emerging biomass ...
Cached Biology Technology:Tecnalia leads the integration of energy efficiency in sports facilities 2Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference 2Argus Launches North American Wood Chip Price Assessments 2
(Date:2/23/2015)... 23, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62114357 for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD ... a new groundbreaking payment method. Payment accounts may be ... only be accessed if both the speech (the word ...
(Date:2/18/2015)... 2015  Cepheid (NASDAQ: CPHD ) today announced ... and invited investors to participate via webcast. , Cowen ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern Time ... FL Wednesday, March 4, 2015 at 10.25 a.m. ... live webcasts for these events, please visit Cepheid,s website at ...
(Date:2/12/2015)...   MedNet Solutions , a global life ... systems, has recently bolstered its iMedNet™ ... iMedNet as the eClinical solution of ... consultants.  Building on the Program,s existing benefits (including ... co-marketing opportunities), MedNet,s new and improved program provides ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3Cepheid to Webcast Upcoming Financial Presentations 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... intimately familiar with the awe-inspiring photos of space shuttle launches ... But how many people have paused for even a second ... a two-week space shuttle mission or are living for months ... book The Astronaut,s Cookbook Tales, Recipes, and More ...
... 13 BIO-key International, Inc. (OTC Bulletin Board: BKYI), ... identification solutions, today reported results for the third quarter ... The Company,s results reflected operating profitability for each quarter ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) , As a result of ...
... DALLAS Nov. 12, 2009 UT Southwestern ... to date for basic and patient-oriented research from the ... billion stimulus package President Barack Obama signed into law ... the National Science Foundation (NSF) and the National Institutes ...
Cached Biology News:The astronaut's cookbook 2BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 2BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 3BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 4BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 5BIO-key(R) Reports Fourth Consecutive Quarter of Operating Profitability 6UT Southwestern receives $42 million in Recovery Act stimulus funding 2UT Southwestern receives $42 million in Recovery Act stimulus funding 3
MAb to HSV-2, gG-2 HSV-2 Glycoprotein G-2...
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
human Exodus-2 Research Focus: cytokine/growth factor Storage Temperature: -20C Shipping Temperature: 4C...
MAb to IgG2 (Fc gamma-2) IgG2 (Fc, gamma-2 epitope)...
Biology Products: